This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (89)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Cardiovascular System  • Alert me on articles by topic  Social Bookmarking   What's this?

Mark. A. Crowther, MD; Jeff B. Ginsberg, MD; Clive Kearon, MB, PhD; Linda Harrison, RN; J. Johnson, RN; M. Patricia Massicotte, MD; Jack Hirsh, MD

Arch Intern Med. 1999;159:46-48.

Background  Warfarin sodium therapy is usually initiated with a loading dose to reduce the time required to elevate the international normalized ratio (INR). Warfarin loading doses are associated with early overanticoagulation and the development of a potential hypercoagulable state; they also may not hasten achieving an INR value between 2.0 and 3.0. This study was designed to prospectively confirm our observation that a 5-mg warfarin sodium loading dose is as effective as a 10-mg loading dose in achieving a therapeutic INR for 2 consecutive days on days 3 and 4 or 4 and 5 of therapy.

Methods  Fifty-three patients initiating warfarin therapy with a target INR of 2.0 to 3.0 were randomly allocated to receive an initial dose of 5 or 10 mg of warfarin. Subsequent doses were based on dosing algorithms. The INR was measured daily for 5 days. The primary end point of the study was the proportion of patients whose INR values were between 2.0 and 3.0 on 2 consecutive daily determinations on days 3, 4, or 5 of the study and whose INR did not exceed 3.0 at any point during the study.

Results  Five (24%) of 21 patients in the 10-mg group and 21 (66%) of 32 patients in the 5-mg group achieved the primary end point (relative risk 2.22, 95% confidence interval 1.30-3.70 [P < .003]). A trend toward less overanticoagulation was seen in the 5-mg warfarin group.

Conclusion  A 10-mg loading dose of warfarin is unlikely to be more effective than a 5-mg loading dose in achieving an INR of 2.0 to 3.0 by day 4 or 5 of therapy.

From the Hamilton Civic Hospitals Research Centre (Drs Crowther, Kearon, and Hirsh, and Ms Harrison), Hamilton General Hospital (Ms Johnson), McMaster University Medical Centre (Dr Ginsberg), Hamilton, and the Hospital for Sick Children, Toronto (Dr Massicotte), Ontario.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Comparing 5-mg and 10-mg Warfarin Loading Doses: Are the Groups Similar?
Steven Angelo, Robert J. Nardino, and Mark A. Crowther
Arch Intern Med. 1999;159(14):1624-1625.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malabsorption-associated warfarin resistance
Sabol et al.
Am J Health Syst Pharm 2009;66:1548-1553.
ABSTRACT | FULL TEXT  

Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
Garcia et al.
The Annals of Pharmacotherapy 2008;42:979-988.
ABSTRACT | FULL TEXT  

Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Ansell et al.
Chest 2008;133:160S-198S.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Kearon et al.
Chest 2008;133:454S-545S.
ABSTRACT | FULL TEXT  

Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients
Lenzini et al.
The Annals of Pharmacotherapy 2007;41:1798-1804.
ABSTRACT | FULL TEXT  

Genetic-based dosing in orthopedic patients beginning warfarin therapy
Millican et al.
Blood 2007;110:1511-1515.
ABSTRACT | FULL TEXT  

Implementing anticoagulation management by pharmacists in the inpatient setting
Dager and Gulseth
Am J Health Syst Pharm 2007;64:1071-1079.
ABSTRACT | FULL TEXT  

Use of specific indicators to detect warfarin-related adverse events
Hartis et al.
Am J Health Syst Pharm 2005;62:1683-1688.
ABSTRACT | FULL TEXT  

Current and emerging treatment options for venous thrombosis: A case discussion
Haines and Nutescu
Am J Health Syst Pharm 2005;62:593-605.
FULL TEXT  

Initiating Warfarin Therapy: 5 mg versus 10 mg
Eckhoff et al.
The Annals of Pharmacotherapy 2004;38:2115-2121.
ABSTRACT | FULL TEXT  

The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Buller et al.
Chest 2004;126:401S-428S.
ABSTRACT | FULL TEXT  

Initial Treatment of Venous Thromboembolism
McRae and Ginsberg
Circulation 2004;110:I-3-I-9.
ABSTRACT | FULL TEXT  

Randomized Trial of Warfarin Nomograms
Peterson and Jackson
ANN INTERN MED 2004;140:488-488.
FULL TEXT  

Randomized Trial of Warfarin Nomograms
Crowther et al.
ANN INTERN MED 2004;140:490-490.
FULL TEXT  

Randomized Trial of Warfarin Nomograms
DiDomenico
ANN INTERN MED 2004;140:489-490.
FULL TEXT  

Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia
Srinivasan et al.
Arch Intern Med 2004;164:66-70.
ABSTRACT | FULL TEXT  

Long-Term Anticoagulant Therapy
Itskowitz and Schulman
NEJM 2003;349:1976-1977.
FULL TEXT  

Assessment of an Age-Adjusted Warfarin Initiation Protocol
Roberts et al.
The Annals of Pharmacotherapy 2003;37:799-803.
ABSTRACT | FULL TEXT  

Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism: A Randomized, Double-Blind, Controlled Trial
Kovacs et al.
ANN INTERN MED 2003;138:714-719.
ABSTRACT | FULL TEXT  

Comparison of a Nomogramand Physician-Adjusted Dosageof Warfarin for Prophylaxis Against Deep-Vein Thrombosis After Arthroplasty
Anderson et al.
JBJS 2002;84:1992-1997.
ABSTRACT | FULL TEXT  

Warfarin Therapy for an Octogenarian Who Has Atrial Fibrillation
Gage et al.
ANN INTERN MED 2001;134:465-474.
ABSTRACT | FULL TEXT  

Anticoagulation Therapy
Ginsberg et al.
ASH Education Book 2001;2001:339-357.
ABSTRACT | FULL TEXT  

Comparing 5-mg and 10-mg Warfarin Loading Doses: Are the Groups Similar?
Angelo et al.
Arch Intern Med 1999;159:1624-1625.
FULL TEXT  

Reevaluation of Warfarin Loading
Journal Watch Cardiology 1999;1999:4-4.
FULL TEXT  

Determining the Proper Dose of Anticoagulants
JWatch General 1999;1999:2-2.
FULL TEXT